Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomics

Methotrexate (MTX) is a common first-line treatment for new-onset rheumatoid arthritis (RA). However, MTX is ineffective for 30–40% of patients and there is no way to know which patients might benefit. Here, we built statistical models based on serum lipid levels measured at two time-points (pre-tre...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Sci Rep
Main Authors: Maciejewski, Mateusz, Sands, Caroline, Nair, Nisha, Ling, Stephanie, Verstappen, Suzanne, Hyrich, Kimme, Barton, Anne, Ziemek, Daniel, Lewis, Matthew R., Plant, Darren
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2021
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8012618/
https://ncbi.nlm.nih.gov/pubmed/33790392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-86729-7
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki